Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
150 Leser
Artikel bewerten:
(0)

Influence of Managed Care Organizations Increasing Within Pharmaceutical Industry

CHAPEL HILL, N.C., Jan. 17, 2014 /PRNewswire/ --The importance and overall influence of Managed Care operations within the United States has significantly grown within recent years. Consequently, pharmaceutical and biotech organizations are placing an increased importance on the activities carried out by their Managed Care operations, as the strength of these organizations has become closely intertwined with marketplace success. Now, more than ever, leaders must carefully examine their Managed Care resource levels to ensure organizational health and competitiveness.

Recent research by benchmarking firm, Best Practices, LLC found that more than 90% of benchmarked organizations Managed Care functions either utilize a hybrid or a centralized structure. This has shifted since 2003, when 100% of benchmarked organizations utilized a centralized structure. Very few companies have a decentralized structure for their Managed Care functions.

The report, "Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations," provides payer and Managed Care leaders with important benchmarks on the optimal size of U.S. Managed Care groups. Specifically, this primary research will allow Managed Care leaders to assess their efficiency level relative to their peers.

Key study topics include:

  • Overall Staffing Levels
  • Outsourcing Levels
  • Staffing Levels Per Key Activity
  • Staffing Levels Linked to Brands Supported
  • Financial Investment for U.S. Managed Care Groups and Key Activities
  • Staffing Efficiency Measures

This benchmarking research drew participation from 12 participants from 11 pharmaceutical, biotech and medical device companies. The full report contains over 110 benchmark metrics and critical best practices, delivering insights into the most effective Managed Care operations, tactics and activities to provide a recent look at staffing and resourcing levels in Managed Care.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1262.htm.

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.